Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Wasman Jane
Relationship:   Director
City:   Hawthorne
State:   NY
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   262,961    

Indirect Shares

   0      
Direct Value   $195,656    

Indirect Value

   $0      
Total Shares   262,961      
Total Value   $195,656      


Acorda Therapeutics Inc $58,945 Rigel Pharmaceuticals Inc $122,000 SELLAS Life Sciences Group Inc $14,560 Athersys Inc (New) $151 Acorda Therapeutics Inc $58,945 Rigel Pharmaceuticals Inc $122,000 SELLAS Life Sciences Group Inc $14,560 Athersys Inc (New) $151
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Acorda Therapeutics Inc ACOR President, Intl and GC 2019-12-02 117,420 0    Premium*  
            Rigel Pharmaceuticals Inc RIGL 2024-05-25 100,000 2021-05-19 0    Premium*  
            SELLAS Life Sciences Group Inc SLS Director 2024-01-22 10,400 2022-01-31 0    Premium*  
            Athersys Inc (New) ATHX Director 2023-01-09 35,141 2022-09-16 0    Premium*  
* Premium Members only  

Records found :    83         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2008-06-11 4 OE $5.85 $20,475 D/D 3,500 29,664 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2015-11-04 4 OE $5.85 $99,596 D/D 16,822 114,919 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2015-12-22 4 OE $5.85 $31,251 D/D 5,342 113,921 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2015-12-23 4 OE $5.85 $62,893 D/D 10,751 110,875 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2015-12-17 4 OE $6.00 $19,662 D/D 3,277 112,673 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2014-08-27 4 OE $8.14 $121,473 D/D 14,923 120,207 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2014-09-24 4 OE $8.14 $121,473 D/D 14,923 120,207 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2014-11-03 4 OE $8.14 $121,473 D/D 14,923 116,457 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2016-09-23 4 OE $8.50 $4,250 D/D 500 109,271 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2019-02-21 4 D $13.38 $12,751 D/D (953) 106,834 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2006-11-07 4 AS $14.89 $1,489 D/D (100) 40,615 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2006-11-07 4 AS $14.91 $102,197 D/D (6,700) 40,715 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2006-11-10 4 AS $15.13 $73,612 D/D (4,851) 35,764 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2006-11-07 4 AS $15.50 $129,104 D/D (8,200) 47,415 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2006-11-06 4 AS $15.90 $353,121 D/D (22,000) 55,615 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2008-12-01 4 AS $15.98 $39,950 D/D (2,500) 23,664 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2007-08-10 4 AS $16.68 $41,307 D/D (2,425) 28,139 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2007-09-26 4 AS $18.56 $45,583 D/D (2,425) 25,714 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2007-11-12 4 AS $18.57 $45,551 D/D (2,425) 20,864 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2008-05-12 4 AS $19.00 $46,341 D/D (2,425) 26,164 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2018-01-19 4 OE $19.81 $683,841 D/D 34,520 136,630 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2018-03-05 4 OE $19.81 $59,034 D/D 2,980 111,553 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2007-10-23 4 AS $19.95 $48,813 D/D (2,425) 23,289 0 -
ACOR Acorda Therapeutics Inc President, Intl and GC   •       –      –    2018-11-05 4 D $20.28 $19,367 D/D (955) 108,354 0 -
ACOR Acorda Therapeutics Inc Exec VP, General Counsel & Sec   •       –      –    2007-12-21 4 AS $20.50 $49,852 D/D (2,425) 18,439 0 -
  83  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us